CalciMedica, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
CALC Nasdaq 2830 calcimedica.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for CalciMedica, Inc.

CalciMedica Announces FDA Alignment on Phase 2b Trial Design for Auxora in Acute Pancreatitis and Identifies Disease's First Potential Registrational Endpoints - Jul 29th, 2026 5:00 am
CalciMedica Announces Private Placement Financing for Up to Approximately $49 Million to Advance Pulmonary Hypertension Program - Jun 24th, 2026 5:01 am
CalciMedica Announces Clinical Development of Auxora May Proceed Following FDA Review of KOURAGE Trial Interim Safety Data - Jun 24th, 2026 5:00 am
CalciMedica Reports First Quarter 2026 Financial Results and Provides Clinical & Corporate Updates - May 12th, 2026 5:00 am
CalciMedica Reports 2025 Financial Results and Provides Clinical Updates - Mar 3rd, 2026 5:00 am
CalciMedica’s stock drops 75% on acute kidney injury trial termination - Jan 29th, 2026 5:24 am
CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation - Jan 28th, 2026 5:00 am
CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates - Nov 12th, 2025 5:01 am
CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial Hypertension - Nov 12th, 2025 5:00 am
CalciMedica Presents Data from Preclinical Study of Auxora™ in an Animal Model of AKI at ASN Kidney Week 2025 - Nov 10th, 2025 5:00 am
CalciMedica and Telperian Announce Collaboration to Integrate Innovative Artificial Intelligence Engine to Analysis of Clinical Trials of Auxora™ - Oct 14th, 2025 5:00 am
CalciMedica to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - Sep 2nd, 2025 5:00 am
CalciMedica Reports Second Quarter 2025 Financial Results and Provides Clinical & Corporate Updates - Aug 12th, 2025 5:00 am